Dr. Steve James Kleronomos

D.D.S. | Dentist



  
  8301 S Brandon Ave, Chicago
  Illinois, 60617-2656

  773-375-6199    Maps & Directions
Dr. Steve James Kleronomos is a Chicago, Illinois based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 8301 S Brandon Ave, Chicago. Patients can reach him at 773-375-6199.
Dr. Steve James Kleronomos is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Steve James Kleronomos speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Steve James Kleronomos
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:8301 S Brandon Ave, Chicago,
Illinois, 60617-2656
Phone:773-375-6199
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 9931409802
Enrollment ID: I20151125000504
NPI Number: 1881768729
NPI Enumeration Date: 20 Nov, 2006
NPI Last Update On: 09 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 8000 Kilpatrick Ave,
Skokie, Illinois
Zip: 60076-3013
Phone Number: 847-677-0129
Patients can reach Dr. Steve James Kleronomos at 8301 S Brandon Ave, Chicago, Illinois or can call to book an appointment on 773-375-6199. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: